Research Topic · Peer-Reviewed

Hpv-16

HPV-16 is a type of human papillomavirus (HPV) that affects the skin and mucous membranes. It is one of the most common types of HPV, and it is most closely associated with the development of cervical, anal, and oropharyngeal cancers. While HPV-16 is responsible for the majority of HPV-related cancers, it can also c…

Curated from this journal's research 📚 2 peer-reviewed articles cited Cited 2× across the literature 🔖 ISSN 2690-4837 🗓 Reviewed June 2026

Overview

HPV-16 is a type of human papillomavirus (HPV) that affects the skin and mucous membranes. It is one of the most common types of HPV, and it is most closely associated with the development of cervical, anal, and oropharyngeal cancers. While HPV-16 is responsible for the majority of HPV-related cancers, it can also cause genital warts. Vaccination against HPV-16 is a safe and effective way to reduce rates of HPV-related cancers. Many countries have implemented HPV-16 vaccination programs in order to reduce the burden of HPV-related cancers. The World Health Organization strongly recommends that all individuals aged 11 to 45 receive HPV-16 vaccination to protect themselves from the risk of HPV-related cancers.

Research published in this journal

2 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 2 articles above have been cited 2 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Oct 2025.

A sample of recent works citing this journal's research on Hpv-16, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in International Journal of Infection Prevention (ISSN 2690-4837).

Journal editorial board
Tetsuya Suzuki · Japan Yosra A. Helmy · United States

This page summarises published research for orientation; it is not medical or professional advice.